Finerenone Outperforms Spironolactone for Cardiorenal Protection in Moderate CKD
🔓 Free Teaser Analysis Nephrology / Renal Pharmacy Confirmatory Grade: Moderate
Georgianos PI, Leptokaridou-Mourtzila E, Kourtidou C, et al.
Jul 20, 2026 · Published in: American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
Finerenone emerges as the safer choice for CKD patients.
Perioperative Dapagliflozin Halves Postoperative AKI After Cardiac Surgery
Analysis Nephrology / Renal Pharmacy Hypothesis-generating Grade: Moderate
Oosterom-Eijmael MJP, Hulst AH, de Oliveira NPM, et al.
Jul 30, 2026 · Published in: JAMA
Dapagliflozin cuts acute kidney injury risk post-cardiac surgery.
Terlipressin Linked to Lower In-Hospital Mortality in HRS-AKI
Analysis Nephrology / Renal Pharmacy Hypothesis-generating Grade: Very Low
Johnson HN, Juang PA
Jul 25, 2026 · Published in: The Annals of Pharmacotherapy
Terlipressin shows promise in lowering HRS-AKI mortality compared to standard treatments.
International Hypertension Guidelines in CKD: ESH, ESC, KDIGO, and AHA/ACC Compared
Guideline Nephrology / Renal Pharmacy Confirmatory Grade: Moderate
Stambolliu E, Stathopoulou E, Bora M, et al.
Jul 9, 2026 · Published in: Clinical Hypertension
Navigating global hypertension guidelines in CKD can enhance patient care.
Dual NSAID Analgesia After Robotic Renal Surgery Shows No AKI Signal
Analysis Nephrology / Renal Pharmacy Hypothesis-generating Grade: Low
Song SH, Lee S, Ryu JH, et al.
Jul 6, 2026 · Published in: Investigative and Clinical Urology
Adding acetaminophen/ibuprofen to ketorolac PCA is safe for kidneys post-renal surgery.
KDIGO Consensus Reframes Kidney Function Changes in Heart Failure
Analysis Nephrology / Renal Pharmacy Confirmatory Grade: Low
Lam CSP, Bozkurt B, Cherney DZI, et al.
Jun 6, 2026 · Published in: Kidney International
CKD and HF coexistence demands integrated management strategies.
Finerenone Slows eGFR Decline in Non-Diabetic CKD
Analysis Nephrology Practice-changing Grade: Moderate
Heerspink HJL, Neuen BL, Agarwal R, et al.
Jan 1, 2026 · Published in: Unknown
FIND-CKD extends the kidney-protective role of finerenone from diabetic to non-diabetic chronic kidney disease, giving pharmacists a new evidence-based add-on to renin-angiotensin system blockade.
Finerenone Cuts Heart Failure Events in Preserved Ejection Fraction
Analysis Nephrology / Renal Pharmacy Practice-changing Grade: High
Pitt B, Filippatos G, Agarwal R, et al.
Aug 28, 2021 · Published in: New England Journal of Medicine
Finerenone reduces cardiovascular events in diabetes with kidney disease.
Finerenone Slows CKD Progression in Type 2 Diabetes
Analysis Nephrology / Renal Pharmacy Practice-changing Grade: High
Bakris GL, Agarwal R, Anker SD, et al.
Oct 23, 2020 · Published in: New England Journal of Medicine
Finerenone reduces kidney and cardiovascular risks in diabetes patients.